BioSpace News Archive

- Fireside chat will address KRAS inhibition and the promise of onvansertib as a new therapeutic option in colorectal cancer

PharmOptima, a member of Genesis Drug Discovery & Development, the contract research organization arm of Genesis Biotechnology Group®, has announced the appointment of Anthony Rohr as its new Chief Executive Officer.

Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that company management will be presenting at the 2020 Wedbush PacGrow Healthcare Virtual Conference. The presentation will take place on Tuesday, August 11, 2020 at 2:20 PM EDT. A live webcast of each presentation will be available on the

Ceapro Inc. announced that positive results demonstrating the anti-inflammatory and immunomodulating properties of avenanthramides have been accepted for publication in the international, peer-reviewed Journal of theInternational Society of Sports Nutrition.

Bio Conscious Technologies Inc. a Prevention-as-a-Service™ technology company using machine learning to predict and manage chronic diseases, is announcing that its Diabits users have experienced positive blood glucose outcomes following the COVID-19 lockdown.

– Cocrystal has two exclusive licenses for the coronavirus protease inhibitors described in the publication – – Cocrystal is currently further conducting preclinical studies of these coronavirus protease inhibitors (3CL) – BOTHELL, WA, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, today announced the publication of preclinical an

Arch Biopartners Inc., announced that it received independent Institutional Review Board approval for the Phase II trial of its lead drug LSALT peptide targeting acute lung injury and acute kidney injury caused by inflammation in patients with severe cases of COVID-19.

Funding will support two randomized, multi-center clinical trials in COVID-19 patients, expansion of manufacturing capacity and potential Emergency Use Authorization filing

CRH Medical Corporation, announces that it has completed an accretive transaction whereby the Company has acquired a 66% interest in Orange County Anesthesia Associates, LLC, a gastroenterology anesthesia practice located in Florida.

IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Pravin U. Dugel, MD, Executive Vice President and Chief Strategy and Business Officer, will present an overview of the Company at the Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 12, 2020 at 9:10 a.m. Eastern Time. Investors and the general public are invited to listen to a live webcast of the presentation available on the Investor / Events & P